title: Is chronic levodopa therapy associated with distal symmetric polyneuropathy in Parkinson's disease?
authors.forename: Nortina
authors.initials: N
authors.lastname: Shahrizaila
authors.forename: Ummi Affah
authors.initials: UA
authors.lastname: Mahamad
authors.forename: Ann-Chee
authors.initials: AC
authors.lastname: Yap
authors.forename: Yeun-Mun
authors.initials: YM
authors.lastname: Choo
authors.forename: Connie
authors.initials: C
authors.lastname: Marras
authors.forename: Shen-Yang
authors.initials: SY
authors.lastname: Lim
mesh_terms: D000328:Adult; D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D011115:Polyneuropathies / Q000139:chemically induced* / Q000453:epidemiology; D015995:Prevalence
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa